We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy... Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Show more
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEW YORK, April 4, 2024 NEW YORK, April 4, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the...
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update PR Newswire QUEENSBURY, N.Y., March 26, 2024 Increases 2024 Treatment Site Activation Guidance to 20...
Delcath Systems Closes $7 Million Private Placement PR Newswire NEW YORK, March 20, 2024 NEW YORK, March 20, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology...
Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call PR Newswire NEW YORK, March 19, 2024 NEW YORK, March 19, 2024 /PRNewswire/ -- Delcath Systems...
Delcath Systems Appoints Martha S. Rook as Chief Operating Officer PR Newswire NEW YORK, March 18, 2024 NEW YORK, March 18, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the...
Delcath Systems Announces $7 Million Private Placement PR Newswire NEW YORK, March 15, 2024 NEW YORK, March 15, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional...
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEW YORK, March 8, 2024 NEW YORK, March 8, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH...
Delcath Systems to Participate in Upcoming Investor Conferences PR Newswire NEW YORK, March 8, 2024 NEW YORK, March 8, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.5316 | 11.1446540881 | 4.77 | 5.7415 | 4.62 | 278122 | 5.35074097 | CS |
4 | 0.5316 | 11.1446540881 | 4.77 | 5.7415 | 4.26 | 234194 | 5.01804331 | CS |
12 | 0.5716 | 12.0845665962 | 4.73 | 5.7415 | 3.7 | 206311 | 4.62557115 | CS |
26 | 1.9016 | 55.9294117647 | 3.4 | 5.7415 | 2.25 | 292517 | 3.78520299 | CS |
52 | -0.4284 | -7.47643979058 | 5.73 | 7.99 | 2.25 | 735715 | 5.09979511 | CS |
156 | -6.1584 | -53.7382198953 | 11.46 | 14.95 | 2.25 | 274102 | 5.34103665 | CS |
260 | 1.5316 | 40.625994695 | 3.77 | 25.18 | 2.25 | 237208 | 6.47452033 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions